QCM
INBX icon

Quantinno Capital Management’s Inhibrx INBX Stock Holding History

Quantinno Capital Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.19M Buy
17,704
+7,666
+76% +$569K ﹤0.01% 2009
2025
Q4 		$793K Sell
10,038
-1,789
-15% -$122K ﹤0.01% 1982
2025
Q3 		$398K Buy
+11,827
New +$291K ﹤0.01% 2218

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Quantinno Capital Management's INBX Position: Q1 2026 in Review

Quantinno Capital Management increased its Inhibrx (INBX) stake by 76% in Q1 2026, buying an estimated $569K and bringing the position to 17,704 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #2009.

Quantinno Capital Management first reported a position in INBX in Q3 2025 and has held it in 3 quarters since. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Quantinno Capital Management held 17,704 shares of Inhibrx worth $1.19M as of Q1 2026.
  • Quantinno Capital Management bought 7,666 Inhibrx shares in Q1 2026, an estimated $569K.
  • Inhibrx made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #2009 holding.
  • Quantinno Capital Management first reported a position in Inhibrx in Q3 2025 and has held it in 3 quarters since.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.